Target intelligence / Profile preview

TEDC2 antisense RNA 1 (TEDC2-AS1)

Target: TEDC2-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA, Noncoding gene

Overview

TEDC2 antisense RNA 1 (TEDC2-AS1) is a long non-coding RNA gene expressed from the antisense strand of the TEDC2 locus. As an antisense RNA, TEDC2-AS1 may regulate the expression of its sense counterpart or other neighboring genes via transcriptional interference, chromatin modification, or RNA-RNA interactions. Antisense lncRNAs in general are involved in diverse cellular processes like epigenetic regulation, control of gene transcription, and post-transcriptional modulation, but as of now, no specific biological role, disease association, or drug interaction is known for TEDC2-AS1 itself. Its function is presumed to be regulatory due to its RNA class, but further functional or clinical relevance is yet to be determined.

Other names: TEDC2-AS1TEDC2 antisense RNA 1

Biological functions

Regulation of gene expression (by antisense transcriptional mechanisms)Modulation of chromatin structure (potentially affecting nearby gene transcription)Possible involvement in developmental and cell differentiation regulation (as with other as-lncRNAs)

Disease associations

Cancer (many antisense lncRNAs have roles in regulating genes associated with tumorigenesis or cancer cell biology, though a direct link for TEDC2-AS1 is not yet established)Other (potential regulatory functions inferred from antisense lncRNAs generally; specific disease roles for TEDC2-AS1 remain unclear)

Beyond the preview

Go deeper on TEDC2 antisense RNA 1 (TEDC2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TEDC2 antisense RNA 1 (TEDC2-AS1).

Explore the full profile